Výsledky vyhledávání

Drug interactions with sunitinib

Autor: Beatriz Baza, Laura Serrano, Amaya De Basagoiti, Zuriñe Baskaran, Ainhoa Belaustegui, M. Castaño, Idoia Bilbao-Meseguer, S Sautua, Leocadio R Lopez-Gimenez, Begoña San Jose, Maria A Gil, A. Bustinza

Publikováno v: Journal of Oncology Pharmacy Practice. 21:52-66

Purpose Sunitinib is a tyrosine kinase inhibitor indicated for the treatment of gastrointestinal stromal tumor, advanced renal cell carcinoma, and pancreatic neuroendocrine tumors. The aim of this article is to describe the pharmacological interactio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b5a4190ef4734d012e8485a6f980399
https://doi.org/10.1177/1078155213516158

Zobrazit plný text záznamu

[Medication reconciliation at hospital admission: Results and identification of target patients]

Autor: B, San José Ruiz, L, Serrano De Lucas, L R, López-Giménez, B, Baza Martínez, S, Sautua Larreategi, A, Bustinza Txertudi, Á, Sebastián Leza, M T, Chirivella Ramón, J L, Fonseca Legrand, M, de Miguel Cascon

Publikováno v: Revista de calidad asistencial : organo de la Sociedad Espanola de Calidad Asistencial. 31

To quantify and to classify the discrepancies between the admission treatment and the usual patient treatment. To determine the variables that predict those patients that will have more benefit from medication reconciliation.A prospective medication

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7aa5f31e22c283c15560972a2fc6b6bf
https://pubmed.ncbi.nlm.nih.gov/27156158

Zobrazit plný text záznamu

DGI-023 Description of Omalizumab Use For the Treatment of Asthma After Four Years of Experience

Autor: L Serrano Lucas De, I Bilbao Meseguer, A De Basagoiti Gorordo, Z Baskaran Kaltzakorta, A Bustinza Txertudi, A Belaustegui Foronda, J Hernandez Goicoechea, E Rodriguez España, B Baza Martinez, S. Sautua Larreategui

Publikováno v: European Journal of Hospital Pharmacy. 20:A103.3-A103

Background Omalizumab’s labelled indication is the treatment of IgE-mediated asthma. It has been used in our hospital since 2008. In 2011 it became necessary to develop a protocol that clarified patient selection and criteria for withholding treatm

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::aed5716de503cac9888df41d5b319536
https://doi.org/10.1136/ejhpharm-2013-000276.289

Zobrazit plný text záznamu

GRP-110 Linezolid Adverse Reactions. A One Year Overview

Autor: B. Baza, A. de Basagoiti, L. Serrano de Lucas, E. Rodriguez, A Belaustegi, J Hernández, I. Bilbao, S Sautua, M. Castaño, Z. Baskaran

Publikováno v: European Journal of Hospital Pharmacy. 20:A40.1-A40

Background Linezolid is an antimicrobial approved for the treatment of hospital or community-acquired pneumonia and complicated skin and soft tissue infections due to Gram positive bacteria. Its use, though effective, is not free from possible harm.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c6fe2d009de0550908a13937956abc42
https://doi.org/10.1136/ejhpharm-2013-000276.110

Zobrazit plný text záznamu

OHP-021 Development and Implementation of a Peripheral Standard Parenteral Nutrition For a Neonatology Department

Autor: M Castaño Lopez, A Belaustegi Foronda, A De Basagoiti Gorordo, S. Sautua Larreategi, I Bilbao Meseguer, J Hernandez Goicoechea, E Rodriguez España, B San Jose Ruiz, Z Baskaran Kaltzakorta, B Sordo Aisa

Publikováno v: European Journal of Hospital Pharmacy. 20:A143.1-A143

Background Parenteral nutrition (PN) for neonates has to be infused by a central line, due to the high osmolarity resulting from the recommended requirements. The central catheter frequently needs to be removed, and therefore PN may have to be admini

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::71c9881584cf1eaee89c7adcb2aec1ff
https://doi.org/10.1136/ejhpharm-2013-000276.395

Zobrazit plný text záznamu

PHC-027 The Pharmacist’s Role in Improving Valproic Acid Prescriptions

Autor: Z. Baskaran, S Sautua, A. Bustinza, A. de Basagoiti, J Hernández, M. Castaño, A Belaustegi, B. San José, M.A. Gil, I. Bilbao

Publikováno v: European Journal of Hospital Pharmacy. 20:A134.3-A135

Background Valproic acid (VPA) is 90–95% protein bound to albumin; this binding can be saturated so other parameters that can modify the free fraction of VPA should be taken into account. Purpose To identify areas for improvement in VPA use and mon

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d3bec0c54a16bb57797b91fc922d63cb
https://doi.org/10.1136/ejhpharm-2013-000276.372

Zobrazit plný text záznamu

Hospital formulations for the treatment of non-albicans vulvovaginitis

Autor: S Sautua, L. Serrano, I. Bilbao, B. Baza, B. San José, Z. Baskaran, M. Castaño, E. Rodriguez, B. Sordo, A. Bustinza

Publikováno v: European Journal of Hospital Pharmacy. 19:142.2-142

Background As vaginal flucytosine is not commercially available, it is necessary to prepare this formulation in the Pharmacy Department. Purpose To describe the preparation of flucytosine 15.5% (FLUCY15.5), and flucytosine 17% + amphotericin 3% (FLUA

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::68171475fd62fd599b7158ea94192bd6
https://doi.org/10.1136/ejhpharm-2012-000074.152

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání